{"url_path":"/sec/afjk/8-k/2026-07-08/item-7-01","section_key":"item-7-01","section_title":"Item 7.01 Regulation FD Disclosure**","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-07-08","source_url":"https://www.sec.gov/Archives/edgar/data/1979005/0001493152-26-032541-index.html","accession_number":"0001493152-26-032541","cik":"0001979005","ticker":"AFJK","issuer_name":"Aimei Health Technology Co., Ltd.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1979005/0001493152-26-032541-index.html","primary_entity_key":"0001979005","primary_entity_name":"Aimei Health Technology Co., Ltd."},"word_count":113,"has_tables":true,"body_markdown":"**Item\n7.01 Regulation FD Disclosure**\n\n \n\nOn\nJuly 7, 2026, the Company issued a press release announcing the termination of the Business Combination Agreement. The Company\nhas filed a copy of the press release as Exhibit 99.1 hereto, and it is incorporated by reference herein.\n\n \n\nThe\nforegoing (including Exhibit 99.1) is being furnished pursuant to Item 7.01 and will not be deemed to be filed for purposes of Section\n18 of the Securities and Exchange Act of 1934, as amended (the “*Exchange Act*”), or otherwise be subject to the liabilities\nof that section, nor will it be deemed to be incorporated by reference in any filing under the Securities Act or the Exchange Act."}